Zealand Pharma A/s
(NASDAQ) ZEAL
This security has been delisted. This page is retained for historical reference.
ZEAL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowZEAL Financials
Key Financial Metrics (TTM)
Gross Margin
99.72%
Operating Margin
73.88%
Net Income Margin
69.22%
Return on Equity
42.59%
Return on Capital
-59.63%
Return on Assets
41.80%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
DKK 108.18M
Operating Income
-DKK 1.14B
EBITDA
-DKK 997.31M
Operating Cash Flow
-DKK 1.30B
Capital Expenditure
-DKK 23.88M
Free Cash Flow
-DKK 1.32B
Cash & ST Invst.
DKK 1.12B
Total Debt
DKK 790.20M
Zealand Pharma A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
DKK 15.08M
-76.2%
Gross Profit
DKK 12.17M
-65.3%
Gross Margin
80.69%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
237
N/A
Net Income
-DKK 181.04M
+52.4%
EBITDA
-DKK 191.93M
+45.5%
Quarterly Fundamentals
Total Cash
DKK 1.12B
-3.0%
Total Debt
DKK 790.20M
+559.3%
Accounts Receivable
DKK 92.58M
+629.3%
Inventory
DKK 3.76M
-91.8%
Long Term Debt
DKK 776.98M
+616.4%
Short Term Debt
DKK 13.22M
+16.0%
Return on Assets
41.80%
N/A
Return on Invested Capital
45.83%
N/A
Free Cash Flow
-DKK 320.75M
-17.6%
Operating Cash Flow
-DKK 317.01M
-14.4%